Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual Meeting

Relief Therapeutics Holding SA / Key word(s): Study results Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data a...

Related Keywords

Geneva ,Genè ,Switzerland ,Florida ,United States ,Orlando ,Swiss ,Jim Denike ,Michael Miller ,Hans Vitzthum ,Raghuram Ram Selvaraju ,Jack Weinstein ,Advita Lifescience Gmb ,Society For Inherited Metabolic Disorders ,Pharma Research ,Drug Administration ,Swiss Exchange ,Rx Communications Group ,Nasdaq ,Exchange Commission ,European Medicines Agency ,Society For Inherited Metabolic Disorders Annual Meeting ,Relief Therapeutics Holding ,Acer Therapeutics Inc ,Neurorx Inc ,Relief Therapeutics Announce Presentation ,Inherited Metabolic Disorders Annual Meeting ,Inherited Metabolic Disorders ,Annual Meeting ,Adrian Quartel ,Prescription Drug User Fee Act ,Taste Masked Sodium Phenylbutyrate ,Urea Cycle Disorders Under Fasting ,Fed Conditions ,Masked Coating ,Sodium Phenylbutyrate ,Urea Cycle ,Molecular Genetics ,Maple Syrup Urine Disease ,Vasomotor Symptoms ,License Agreement ,Vasoactive Intestinal Peptide ,Acer Therapeutics ,Maple Syrup Urine ,Advita Lifescience Gmbh ,Metabolism Reports ,Private Securities Litigation Reform Act ,Annual Report ,Financial Officer ,